• 1
    Silva MJ, Sandell LJ 2002 What's new in orthopaedic research. J Bone Joint Surg Am 84: 14901496.
  • 2
    Willert HG, Bertram H, Buchhorn GH 1990 Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop 258: 95107.
  • 3
    Ahmed M, Bergstrom J, Lundblad H, Gillespie WJ, Kreiebergs A 1998 Sensory nerves in the interface membrane of aseptic loose hip prosthesis. J Bone Joint Surg Br 80: 151155.
  • 4
    Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM 1982 Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240244.
  • 5
    Beaumont K, Pittner RA, Moore CX, Wolfe-Lopez D, Prickett KS, Young AA, Rink TJ 1995 Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved. Br J Pharmacol 115: 713715.
  • 6
    Leighton B, Foot EA 1995 The role of the sensory peptide calcitonin-gene-related peptide(s) in skeletal muscle carbohydrate metabolism: Effects of capsaicin and resiniferatoxin. Biochem J 307: 707712.
  • 7
    Wimalawansa SJ 1997 Amylin, calcitonin gene related peptide, calcitonin and adrenomedullin: A peptide super-family. Crit Rev Neurobiol 11: 167239.
  • 8
    Wimlalawansa SJ 1996 Calcitonin gene related peptide and its receptors: Molecular genetics, physiology, pathophysiology and therapeutical potentials. Endocr Rev 17: 533585.
  • 9
    Brain SD, Williams TJ 1985 Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 86: 855860.
  • 10
    Yamamoto I, Kitamura N, Aoki J, Shigeno C, Hino M, Asonuma K, Torizaka K, Fujii N, Otaka A, Yajima H 1986 Human calcitonin gene related peptide possesses weak inhibitory potency of bone resorption in vitro. Calcif Tissue Int 38: 339341.
  • 11
    Irie K, Hara-Irie F, Ozawa H, Yajima T 2002 Calcitonin gene related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodelling. Microsc Res Tech 58: 8590.
  • 12
    Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CLH 2002 Forty years of calcitonin—where we are now? A tribute to the work of Iain MacIntyre, FRS. Bone 30: 655663.
  • 13
    Lerner UH 2002 Neuropeptidergic regulation of bone resorption and bone formation. J Musculoskelet Neuronal Interact 2: 440447.
  • 14
    Saxler G, Loer F, Skumavc M, Pfortner J, Hanesch U 2007 Localization of SP- and CGRP-immunopositive nerve fibers in the hip joint of patients with painful osteoarthritis and of patients with painless failed total hip arthroplasties. Eur J Pain 11: 6774.
  • 15
    Saito T, Koshino T 2000 Distribution of neuropeptides in synovium of the knee with osteoarthritis. Clin Orthop 376: 172182.
  • 16
    Bjurholm A, Kreiebergs A, Terenius L, Goldstein M, Schultzberg M 1988 Neuropeptide Y-, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissue. J Auton Nerv Syst 25: 119125.
  • 17
    Bjurholm A, Kreicbergs A, Brodin E, Scultzberg M 1991 Substance P and CGRP immunoreactive nerves in bone. Peptides 9: 165171.
  • 18
    Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR 1999 Comparison of the effects of calcitonin gene related peptide and amylin on osteoblasts. J Bone Miner Res 14: 13021309.
  • 19
    D'Souza SM, MacIntyre I, Girgis SI, Mundy GR 1986 Human synthetic calcitonin gene related peptide inhibits bone resorption in vitro. Endocrinology 119: 5861.
  • 20
    Roos BA, Fischer JA, Pignat W, Alander CB, Raisz LG 1986 Evaluation of the in vivo and in vitro calcium-regulating actions of noncalcitonin peptides produced via calcitonin gene expression. Endocrinology 118: 4851.
  • 21
    Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA, Vignery A 1999 Targeted expression of calcitonin gene related peptide to osteoblasts increases bone density in mice. J Bone Miner Res 14: 10671074.
  • 22
    Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M 2004 Decreased bone formation and osteopenia in mice lacking alpha calcitonin gene related peptide. J Bone Miner Res 19: 20492056.
    Direct Link:
  • 23
    Zaidi M, Fuller K, Bevis J, GainesDas RE, Chambers TJ, MacItyre I 1987 Cacitonin gene related peptide inhibits osteoclastic bone resorption: A comparative study. Calcif Tissue Int 40: 149154.
  • 24
    Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P 2000 Effects of CGRP on human osteoclast-like cell formation: A possible connection with the bone loss in neurological disorders? Peptides 21: 559564.
  • 25
    Lu JT, Son Y-J, Lee J, Jetton JL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB 1999 Mice lacking alpha-calcitonin gene related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci 14: 99120.
  • 26
    von Knoch M, Wedemeyer C, Pingsmann A, von Knoch F, Hilken G, Sprecher C, Henschke F, Barden B, Löer F 2005 The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 26: 18031808.
  • 27
    Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL 1999 Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154: 203210.
  • 28
    Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ 2000 Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18: 472480.
  • 29
    Parfitt AM 1988 Bone histomorphometry: Proposed sytem for standaziation of nomenclature, symbols, and units. Calcif Tissue Int 42: 284286.
  • 30
    Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM 2006 RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology 45: 10681076.
  • 31
    Harris WH 2001 Wear and periprosthetic osteolysis. Clin Orthop 392: 6670.
  • 32
    Willert HG, Bertram H, Buchhorn GH 1990 Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop 258: 95107.
  • 33
    Imai S, Matsusue Y 2002 Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, Substance P-, and Tyrosine hydroxylase-containing nerves and bone. Microsc Res Tech 58: 6169.
  • 34
    Imai S, Tokunago Y, Maeda T, Kikkawa M, Hukuda S 1997 CGRP-, SP-, and TH-immunoreactive innervation of rat bone marrows. An immunhistochemical and ultrastructural investigation on possible efferent and afferent mechanisms. J Orthop Res 15: 133140.
  • 35
    Drissi H, Hott M, Marie PJ, Lasmoles F 1997 Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells. J Bone Miner Res 12: 18051814.
  • 36
    Togari A, Arai M, Mizutani S, Koshihara Y, Nagatsu T 1997 Expression of mRNA for neuropeptide receptors and beta adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci Lett 233: 125128.
  • 37
    Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, Guidobono F 2000 Effects of calcitoin gene-related peptide and amylin on human osteoblast like cells proliferation. Eur J Pharmacol 409: 273278.
  • 38
    Valentijn K, Gutow AP, Troiano N, Gundberg C, Giligan JP, Vignery A 1997 Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269274.
  • 39
    Santavirta S, Konttinen YT, Nordstrom D, Makela A, Sorsa T, Hukkanen M, Rokkanen P 1992 Immunologic studies of nonunited fractures. Acta Orthop Scand 63: 579586.
  • 40
    Aoki M, Tamai K, Saotome K 1994 Substance P- and calcitonin gene related peptide- immunoflorescent nerves in the repair of experimental bone defects. Int Orthop 18: 317324.
  • 41
    Madsen JE, Hukkanen M, Aspenberg P, Polak J, Nordsletten L 2000 Time dependent sensory nerve ingrowths into bone conduction chamber. Acta Orthop Scand 71: 7479.
  • 42
    Lerner UH 2006 Deletions of genes encoding calcitonin/α-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone. J Musculoskelt Neuronal Interact 6: 8795.
  • 43
    Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M 2006 Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res 21: 19241934.
  • 44
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclasts differentiation and activation. Cell 93: 165167.
  • 45
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL a regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis. Nature 397: 315323.
  • 46
    Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97: 15661571.
  • 47
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309319.
  • 48
    Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 13291337.
  • 49
    Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL 1999 Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem 72: 251261.